1. History and introduction of Dong A pharmaceutical
Dong-A Pharmaceutical is the leading pharmaceutical company in Korea. Dong-A stands at the forefront of Korea's pharmaceutical industry; motivated by its respect for life and health to continuously innovate and develop products that enhance people's quality of life. We are working hard to grow internationally and become one of the world's most
Chapter 1. Indian Pharmaceutical Market Overview
1.1 Scale of Pharmaceutical Market
1.1.1 Domestic pharmaceutical market
India is among the fastest growing pharmaceutical markets in the world. The domestic pharmaceutical market recorded sales of US$ 7.3 billion in 2006 with a growth of 17.5 per cent over the previous year.
1.1.2 Pharmaceutical Industry
The Indian pharmaceutical industry
I. Introduction of Hanmi
Hanmi is pharmaceutical company spearheading innovation in life science. Hanmi was established by Lim,Sung Gi in 1973 based on mottoes –“Human Respect” & “Creation of Value”, Hanmi has endless exerted all its power for precious human life. For the purpose of the progress of pharmaceutical industry and the supply of highly qualified medicines with the most
REBATE?
Literally
Paying back a portion of the payment or interest to the payee
In the field of medicine
Pharmaceutical company pays back to the hospital
through negative market
Cause of Rebate in Korea
K-1. Special characteristics of Medical industry
Patients have no option in choice of drugs
Doctors have the incentive to use their
professionalism to maximize their p
to doctors who make decision about pharmaceutical prescription
The goal of this policy is increasing a sense of cost to doctor and improving medical treatment.
Characteristic
Doctors are able to get an incentive when they make a goal that follows the guide-line or expends some cost subject to budget.
Direct way: Affecting doctor’s income
Indirect way: Profit for clinics or patients